Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Current Assets (2023 - 2025)

Upstream Bio (UPB) has 3 years of Current Assets data on record, last reported at $389.0 million in Q3 2025.

  • For Q3 2025, Current Assets rose 71.17% year-over-year to $389.0 million; the TTM value through Sep 2025 reached $389.0 million, up 71.17%, while the annual FY2024 figure was $479.2 million, 309.55% up from the prior year.
  • Current Assets reached $389.0 million in Q3 2025 per UPB's latest filing, down from $418.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $479.2 million in Q4 2024 and bottomed at $117.0 million in Q4 2023.
  • Average Current Assets over 3 years is $347.4 million, with a median of $403.6 million recorded in 2025.
  • Peak YoY movement for Current Assets: skyrocketed 309.55% in 2024, then soared 71.17% in 2025.
  • A 3-year view of Current Assets shows it stood at $117.0 million in 2023, then surged by 309.55% to $479.2 million in 2024, then fell by 18.81% to $389.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $389.0 million in Q3 2025, $418.3 million in Q2 2025, and $453.8 million in Q1 2025.